Sonic Healthcare Limited
SHL
Rang in Aktien
#2829
Sonic Healthcare Limited delivers medical diagnostic services to a diverse... Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
Aktienkurs
$13.26
Marktkapitalisierung
$6.55B
Veränderung (1 Tag)
-0.21%
Veränderung (1 Jahr)
-4.48%
Land
AU
Handel Sonic Healthcare Limited (SHL)
Kategorie
Healthcare
Umsatz von Sonic Healthcare Limited (SHL)
Umsatz im Jun 2026 TTM: $7.72B
Laut den aktuellen Finanzberichten von Sonic Healthcare Limited beträgt der derzeitige Umsatz des Unternehmens (TTM) $7.72B. Im Jahr 2024 erzielte das Unternehmen einen Umsatz von $5.97B eine Steigerung gegenüber dem Umsatz im Jahr 2023, der $5.43B betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für Sonic Healthcare Limited von 2000 bis 2026
Umsatz am Ende jedes Jahres
| Jahr | Umsatz | ändert |
|---|---|---|
| 2026 (TTM) | $7.72B | 21.62% |
| 2025 | $6.35B | 6.44% |
| 2024 | $5.97B | 9.92% |
| 2023 | $5.43B | -15.46% |
| 2022 | $6.42B | -2.19% |
| 2021 | $6.56B | 44.93% |
| 2020 | $4.53B | 5.12% |
| 2019 | $4.31B | 6.21% |
| 2018 | $4.06B | 4.22% |
| 2017 | $3.89B | 5.59% |
| 2016 | $3.69B | 15.59% |
| 2015 | $3.19B | -12.32% |
| 2014 | $3.64B | 16.17% |
| 2013 | $3.13B | -7.83% |
| 2012 | $3.40B | 2.73% |
| 2011 | $3.31B | 31.31% |
| 2010 | $2.52B | 4.80% |
| 2009 | $2.40B | 7.41% |
| 2008 | $2.24B | 42.62% |
| 2007 | $1.57B | 29.80% |
| 2006 | $1.21B | 16.78% |
| 2005 | $1.03B | 45.21% |
| 2004 | $712.48M | 10.16% |
| 2003 | $646.79M | 35.18% |
| 2002 | $478.47M | 51.42% |
| 2001 | $315.99M | 0.00% |
| 2000 | 0.00 | 0.00% |
Umsatz vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Umsatz | Umsatzunterschied | Land |
|---|---|---|---|
| $46.34B | 499.99% |
US
|
|
| $25.11B | 225.10% |
US
|
|
| $2.71B | -64.95% |
US
|
|
| - | - |
CN
|
|
| $7.37B | -4.54% |
US
|
